Impact of low muscle mass and myosteatosis on treatment toxicity and survival outcomes in non-resectable pancreatic cancer patients treated with chemoradiotherapy
Patients with low muscle mass experienced more toxicities and poorer outcomes during CRT for non-resectable PC.
Authors
- Angélique Saint (ORCID: https://orcid.org/0000-0002-3963-6124)
- Damien Botsen (ORCID: https://orcid.org/0000-0002-2117-4750)
- Florian Slimano (ORCID: https://orcid.org/0000-0001-5139-7034)
- Éric Bertin (ORCID: https://orcid.org/0000-0002-8357-985X)
- Manel Djelouah (ORCID: https://orcid.org/0000-0003-0638-4415)
- Claire Carlier (ORCID: https://orcid.org/0000-0002-9889-1424)
- Paolo Torielli
- Marine Perrier (ORCID: https://orcid.org/0000-0002-4528-5471)
- Mathias Brügel (ORCID: https://orcid.org/0000-0001-7574-9364)
- Philippe Guilbert (ORCID: https://orcid.org/0000-0002-2192-2958)
- Olivier Bouché (ORCID: https://orcid.org/0000-0002-8284-3743)
- Marine Fontaine (ORCID: https://orcid.org/0000-0002-9141-238X)
- E. François
Institutions
- Centre Hospitalier Universitaire de Reims (FR)
- Centre Hospitalier de la Côte Basque (FR)
- Centre Antoine Lacassagne (FR)
- Institut Jean Godinot (FR)
- Performance Santé, Métrologie, Société (FR)
- Université de Reims Champagne-Ardenne (FR)
Publication Details
- Journal
- European Journal of Clinical Nutrition
- Published
- 2025-02-05
- DOI
- https://doi.org/10.1038/s41430-025-01566-5
- Citations
- 3
- Primary Topic
- Nutrition and Health in Aging
- Type
- article
- Field-Weighted Citation Impact
- 3.49